preview
Advertisement This month I have the pleasure of interviewing Caroline Baumal, who is professor of Ophthalmology at Tufts University in Boston, MA. Caroline…
Advertisement This month I have the pleasure of interviewing Caroline Baumal, who is professor of Ophthalmology at Tufts University in Boston, MA. Caroline…
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
The Young Uveitis Specialists (YUS) group is a subsection of the American Uveitis Society (AUS). They are a professional group of early career uveitis specialists…
Regeneron’s Eylea HD (aflibercept) injection 8 mg allows patients with wet age-related macular degeneration (wAMD), diabetic macular edema (DME), and diabetic retinopathy (DR) to receive…
Typically, when coding, billing, and documentation are discussed, most people think of Current Procedural Terminology (CPT) and Healthcare Common Procedure Coding System (HCPCS) codes. However,…
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
MAY 2024 VOLUME 21 | NUMBER 4 www.retinalphysician.com POWERED BY Overview of Retinal Prosthesis and Future Directions Promising data may translate to meaningful vision gains.…
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
Harrow’s Iheezo, a topical ocular anesthetic, is the first FDA-approved use of chloroprocaine hydrochloride in the US ophthalmic market.
Retinal physicians face increasing pressure from government regulators and payors on various issues. To avoid regulatory scrutiny, it’s vital for practice administrators and owners to…
Studies have shown upregulation of other VEGF subtypes when VEGF-A is blocked. This has led to several companies targeting VEGF-C and VEGF-D to improve outcomes…